MSB 3.42% $1.21 mesoblast limited

Mesoblast Phase 2 Trial Results Show Early and Durable Effects of Single Mesenchymal Precursor Cell, page-170

  1. 3,374 Posts.
    lightbulb Created with Sketch. 284
    And what exactly would competitors do with trial results if they do ban have the actual treatment IP?

    Other than try to talk it down of course and we already have @hottuna and @madamswer well and truly on that don't we. Oh and me apparently.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.